Cel Sci CVM
NYSE CVM
$1.78 +0.08 (+4.90%)
As of: Sep 29, 2026 · 3:58 PM EDT

Cel Sci (CVM) Convertible Debt (2011)

Updated

Cel Sci (CVM) reported Convertible Debt of $2.96 million for fiscal Q1 2012 (quarter ended Dec 31, 2011), down 40.9% from the prior quarter.

Analysis

Cel Sci (CVM) Convertible Debt (2011) Analysis & Trends

At the end of FY2011 (ended Sep 30, 2011), Cel Sci posted Convertible Debt of $5 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Cel Sci 3.11 Mn -22.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 2.96 Mn
Sep 30, 2011 5.00 Mn
Jun 30, 2011 4.93 Mn
API Access

Cel Sci Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=CVM&period=max&api_key=YOUR_API_KEY